VaxiJen: a server for prediction of protective antigens, tumour antigens and subunit vaccines.
Doytchinova IA, Flower DR. · 2007
Read VaxiJen: a server for prediction of protective antigens, tumour antigens and subunit vaccines. by Doytchinova IA, Flower DR. (2007) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc1780059.txt.
Introduction
Doytchinova and Flower built VaxiJen in 2007, a free web server that predicts which proteins might work as vaccine parts. An antigen is a protein piece that the immune system can learn to attack. Older tools hunted antigens by lining up sequences, which misses new proteins with no close known match.
Their method skips alignment entirely. It turns each protein sequence into a fixed set of numbers based on the main traits of its amino acids, using a transform called auto cross covariance. Models trained on sets built from 100 antigens already known and an equal count of non-antigens covered bacteria, viruses, and tumors. In checks the models scored between 70 and 89 percent correct. VaxiJen was the first server of its kind.
Catalog record
| CREATOR | Doytchinova IA, Flower DR. |
|---|---|
| YEAR | 2007 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 27 KB |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |
Browse the full library · About the Tower of Babel
Full text
The opening of the work, from the library's hosted text:
VaxiJen: a server for prediction of protective antigens, tumour antigens and subunit vaccines By Irini A Doytchinova, Darren R Flower Published in: BMC Bioinformatics DOI: 10.1186/1471-2105-8-4 ABSTRACT Background Vaccine development in the post-genomic era often begins with the in silico screening of genome information, with the most probable protective antigens being predicted rather than requiring causative microorganisms to be grown. Despite the obvious advantages of this approach – such as speed and cost efficiency – its success remains dependent on the accuracy of antigen prediction. Most approaches use sequence alignment to identify antigens. This is problematic for several reasons. Some proteins lack obvious sequence similarity, although they may share similar structures and biological properties. The antigenicity of a sequence may be encoded in a subtle and recondite manner not amendable to direct identification by sequence alignment. The discovery of truly novel antigens will be frustrated by their lack of similarity to antigens of known provenance. To overcome the limitations of alignment-dependent methods, we propose a new alignment-free approach for antigen prediction, which is based on auto cross covariance (ACC) transformation of protein sequences into uniform vectors of principal amino acid properties. Results Bacterial, viral and tumour protein datasets were used to derive models for prediction of whole protein antigenicity. Every set consisted of 100 known antigens and 100 non-antigens. The derived models were tested by internal leave-one-out cross-validation and external validation using test sets. An additional five training sets for each class of antigens were used to test the stability of the discrimination between antigens and non-antigens. The models performed well in both validations showing prediction accuracy of 70% to 89%. The models were implemented in a server, which we call VaxiJen. Conclusion VaxiJen is the first server for alignment-independent prediction of protective antigens. It was developed to allow antigen classification solely based on the physicochemical properties of proteins without recourse to sequence alignment. The server can be used on its own or in combination with alignment-based prediction methods. It is freely-available online at the URL: . BACKGROUND Vaccination is a highly effective approach to disease control in human and veterinary health care. A vaccine is a molecular or supramolecular agent which elicits specific, protective immunity; that is an enhanced adaptive immune response to re-infection by pathogenic microbes through the potentiation of immune memory. Vaccination ultimately mitigates the effect of subsequent infection and disease. Thus, the immune system recognizes vaccine agents as foreign, destroys them, and subsequently 'remembers' them. When the pathogenic microorganism is encountered again, the immune system has been primed to respond, by neutralizing the target before it can enter cells, or/and by destroying infected cells before the microorganism can grow and cause damage. Vaccines have contributed to the eradication of smallpox, the near eradication of polio, and the control of a variety of diseases, including rubella, measles, mumps, chickenpox, typhoid [1]. Vaccines from the pre-genomic era were based on killed or live, but attenuated, microorganisms, or subunits purified from them [2]. Subunit vaccines contain one or more pure or semi-pure antigens. In order to develop subunit vaccines, it is critical to identify those proteins which are important for inducing protection and to eliminate others. An antigen is said to be protective if it is able to induce protection from subsequent challenge by a disease-causing infective agent in an appropriate animal model following immunization. The empirical approach to sub-unit vaccine development, which includes several steps, begins with pathogen cultivation, followed by purification into components, and then testing of antigens for protection [3]. Apart from being time- and labour-consuming, this approach has several limitations that can lead to failure. Vaccines can not be developed using this approach for microorganisms which can not easily be cultured and only allows for the identification of those antigens which can be obtained in sufficient quantities. In some cases, the most abundant proteins are not immunoprotective. In other cases, the antigen expressed during in vivo infection is not expressed during in vitro cultivation. Genomics has revolutionized vaccine research. The ability to sequence the whole genome of a virulent microorganism has led some to screen in silico for the most probable protective antigens before undertaking confirmatory experiments. This approach, known as reverse vaccinology [4], was first used to identify antigens as potential candidate vaccines against serogroup B meningococcus [5]. Apart from obvious advantages – such as speed and low cost – the success of this approach is dependent on the accuracy of antigen prediction, and many bioinformatics tools are available to facilitate this process [6-8]. They can identify surface-associated or outer membrane proteins, signal peptides, lipoproteins, or host-cell binding domains. Most algorithms use sequence alignment to identify antigens. This is problematic for several reasons. Some proteins formed through divergent or convergent evolution lack obvious sequence similarity, although they may share similar structures and biological properties [9]. In such a situation, alignment-based approaches may produce ambiguous results or fail. Moreover, antigenicity, as a property, may be encoded in a sequence in a subtle and recondite manner not amendable to direct identification by sequence alignment. Likewise, the discovery of truly novel antigens will be frustrated by their lack of similarity to antigens of known provenance. To overcome the limitations of alignment-dependent sequence similarity methods, we propose a new alignment-independent method for antigen prediction based on auto cross covariance (ACC) transformation of protein sequences into uniform equal-length vectors. ACC is an protein sequence mining method developed by Wold et al. [10], which has been applied to quantitative structure-activity relationships (QSAR) studies of peptides with different length [11,12] and for protein classification [13]. The ACC transformation accounts for neighbour effects, i.e. the lack of independence between different sequence positions. In the present study, we applied ACC pre-processing to sets of known bacterial, viral and tumour antigens and developed alignment-independent models for antigen recognition based on the main chemical properties of amino acid sequences. The principal properties of the amino acids were represented by z descriptors, originally derived by Hellberg et al. [14] to describe amino acid hydrophobicity, molecular size and polarity. The models were implemented in a server for the prediction of protective antigens and subunit vaccines, which we call VaxiJen. This is freely accessible via the World Wide Web. Our method is the first alignment-free bioinformatics tool for the in silico identification of antigens. RESULTS Three datasets were used in this study: one for bacteria, one for viruses, and one for tumours. Each set consisted of 100 known antigens and 100 non-antigens, collected as described in the Methods section. Each amino acid in the protein sequence was represented by three z descriptors: z1, z2, and z3. Each protein was transformed into a uniform vector, which consisted of 45 ACC terms, by applying ACC pre-processing, as described in the Methods section. The new matrices were imported into SIMCA-P 8.0 [15] and were subject to a two-class discriminant analysis using the partial least squares technique (DA-PLS). The models were validated using leave-one-out cross-validation (LOO-CV) on the whole sets and by external validation using test sets. The test sets were selected randomly to include 25% of the whole sets. Then models were developed based on the remaining 75% and tested on the excluded proteins. The validation results were assessed in terms